Aurinia Pharmaceuticals Inc (AUPH) Social Stream



Aurinia Pharmaceuticals Inc (AUPH): $11.65

0.44 (+3.93%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Aurinia Pharmaceuticals Inc (AUPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AUPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 8 $40 $26 $34.125 $12.5 173%
2021-12-10 8 $40 $26 $33.875 $12.5 171%
2022-01-09 8 $40 $26 $33.625 $12.5 169%
2022-02-10 7 $40 $26 $33.625 $12.5 169%
2022-03-01 8 $34 $23 $31.125 $12.5 149%
2022-03-09 8 $34 $18 $27.437 $12.5 119.5%

The Trend in the Analyst Price Target


Over the past 27 days, AUPH's average price target has gone down $6.19.

AUPH reports an average of 102.36% for its upside potential over the past 125 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-10 8 40 26 33.875 20.13 68.28%
2022-02-10 7 40 26 33.625 18.65 80.29%
2022-03-01 8 34 18 28.875 12.01 140.42%
2022-03-01 8 34 23 31.125 12.01 159.16%
2022-03-08 8 34 18 27.437 10.12 171.12%

AUPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.13 7 1 0 0 0 8

The Trend in the Broker Recommendations


Over the past 19 months, AUPH's average broker recommendation rating worsened by 0.12.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AUPH as an investment opportunity.

  • AUPH has a higher upside potential (average analyst target price relative to current price) than 593.06% of all US stocks.
  • In the context of all US stocks, Aurinia Pharmaceuticals Inc's average analyst price target is higher than 255.82% of them.
  • In the context of Pharmaceutical Products stocks, Aurinia Pharmaceuticals Inc's number of analysts covering the stock is greater than 470.48% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Aurinia Pharmaceuticals Inc's variance in analysts' estimates is lower than -166.75% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Aurinia Pharmaceuticals Inc are ATAI, ASND, and ARWR.

What is the outlook for AUPH? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6008 seconds.